Abdullah Esmail, MD
Houston Methodist Neal Cancer Center
3
0
0
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Maen Abdelrahim, MD, PhD, Pharm D
The Methodist Hospital Research Institute
Shared therapeutic areas:
Worked with same sponsors:
Liangjun Zhu, Dr
Jiangu Cancer Hospital
Shared therapeutic areas:
Hannah Robinson, MD
University of Colorado, Denver
Shared therapeutic areas:
DEZHI LI
4th Affiliated Hospital, School of Medicine, Zhejiang University, China
Shared therapeutic areas:
Jean-Marc JML LIMACHER, Dr
Odimma Therapeutics
Shared therapeutic areas:
Yongkun Sun
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Shared therapeutic areas:
Dr Julie VINCENT
Centre Georges François Leclerc
Shared therapeutic areas:
Namrata Vijayvergia, MD
Fox Chase Cancer Center
Shared therapeutic areas:
Aung Naing, Md
M.D. Anderson Cancer Center
Shared therapeutic areas:
Ruihua Xu, MD
Sun Yat-sen University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer
All 3 trials loaded